查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1541032

2024-2032 年按工作流程、功能、模式、最終用戶（製藥公司、生物技術公司、合約研究組織等）和地區分類的藥物發現資訊學市場報告

Drug Discovery Informatics Market Report by Workflow, Function, Mode, End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2023年，全球IMARC Group發現資訊學市場規模達33億美元。

藥物發現資訊學是一種用於分析和解釋大量生化資料的技術解決方案。這些資料是從臨床實驗室出於研究目的進行的實驗中產生的，並用於產生有關各種藥物開發的見解。它涉及大量基於軟體和硬體的工具，用於藥物發現和開發的測序、目標資料分析、資料可視化、對接、分子建模、資料庫保護。因此，它被醫療機構、製藥和生物技術組織以及合約研究組織 (CRO) 廣泛使用。

全球醫療保健和製藥行業的顯著成長是創造積極市場前景的關鍵因素之一。此外，慢性疾病的盛行率不斷上升，以及對治療罕見疾病的有效解決方案的需求不斷增加，也促進了市場的成長。藥物發現資訊學被製藥組織廣泛用於分析新藥物實體和處理來自多個來源的生物資訊。此外，各種技術進步，例如創新的基於生理學的藥物動力學 (PBPK) 模擬器平台的開發，有助於透過建模和模擬預測藥物動力學結果，也是其他生長誘導因素。與此一致，政府和私人醫療機構增加投資開發孤兒藥也有助於市場成長。其他因素，包括老年人口的增加，以及生物資訊學領域廣泛的研發（R&D）活動，預計將進一步推動市場發展。

本報告回答的關鍵問題：

  • 迄今為止，全球藥物發現資訊學市場表現如何，未來幾年將如何表現？
  • COVID-19 對全球藥物發現資訊學市場有何影響？
  • 主要區域市場有哪些？
  • 基於工作流程的市場區隔是怎樣的？
  • 基於功能的市場區隔是什麼？
  • 基於模式的市場區隔是什麼？
  • 基於最終用戶的市場區隔是什麼？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球藥物發現資訊學市場的結構如何？
  • 產業競爭程度如何？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球藥物發現資訊學市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依工作流程

  • 藥物發現
    • 市場趨勢
    • 市場預測
  • 藥物開發
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：按功能

  • 序列分析平台
    • 市場趨勢
    • 市場預測
  • 分子模擬
    • 市場趨勢
    • 市場預測
  • 分子對接
    • 市場趨勢
    • 市場預測
  • 臨床試驗數據管理
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按模式

  • 外包
    • 市場趨勢
    • 市場預測
  • 內部
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按最終用戶

  • 製藥公司
    • 市場趨勢
    • 市場預測
  • 生技公司
    • 市場趨勢
    • 市場預測
  • 合約研究組織 (CRO)
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Accenture PLC
    • Certara
    • Charles River Laboratories Inc.
    • Collaborative Drug Discovery Inc.
    • Eurofins DiscoverX Products
    • Infosys Ltd.
    • International Business Machines Corporation
    • Jubilant Biosys Limited
    • Oracle Corporation
    • PerkinElmer Inc.
    • Selvita
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A3515

The global drug discovery informatics market size reached US$ 3.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.8 Billion by 2032, exhibiting a growth rate (CAGR) of 9.7% during 2024-2032.

Drug discovery informatics is a technological solution used for analyzing and interpreting large volumes of biochemical data. The data is generated from the experiments conducted in clinical laboratories for research purposes and utilized for generating insights regarding the development of various drugs. It involves numerous software and hardware-based tools for sequencing, target data analysis, data visualization, docking, molecular modelling, database protection for drug discovery and development. As a result, it is widely used by healthcare institutions, pharmaceutical and biotechnology organizations and contract research organizations (CROs).

Significant growth in the healthcare and pharmaceutical industries across the globe represents one of key the factors creating a positive outlook for the market. Furthermore, the increasing prevalence of chronic medical disorders and the escalating requirement for effective solutions to treat rare diseases are also augmenting the market growth. Drug discovery informatics is widely used by pharmaceutical organizations for the analysis of new drug entities and handling of the biological information from multiple sources. Additionally, various technological advancements, such as the development of innovative Physiologically-based Pharmacokinetic (PBPK) Simulator platforms, which aid in predicting pharmacokinetic outcomes through modeling and simulation, are acting as other growth-inducing factors. In line with this, increasing investments by government and private healthcare institutions to develop orphan drugs is also contributing to the market growth. Other factors, including the rising geriatric population, along with extensive research and development (R&D) activities in the field of bioinformatics, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global drug discovery informatics market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on workflow, function, mode and end user.

Breakup by Workflow:

Drug Discovery

Drug Development

Breakup by Function:

Sequence Analysis Platforms

Molecular Modelling

Molecular Docking

Clinical Trial Data Management

Others

Breakup by Mode:

Outsourced

In-house

Breakup by End User:

Pharmaceutical Companies

Biotechnology Companies

Contract Research Organization (CROs)

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture Plc, Certara, Charles River Laboratories Inc., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Infosys Ltd., International Business Machines Corporation, Jubilant Biosys Limited, Oracle Corporation, PerkinElmer Inc., Selvita and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global drug discovery informatics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global drug discovery informatics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the workflow?
  • What is the breakup of the market based on the function?
  • What is the breakup of the market based on the mode?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global drug discovery informatics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Drug Discovery Informatics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Workflow

  • 6.1 Drug Discovery
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Drug Development
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Function

  • 7.1 Sequence Analysis Platforms
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Molecular Modelling
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Molecular Docking
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Clinical Trial Data Management
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Mode

  • 8.1 Outsourced
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 In-house
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Biotechnology Companies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Contract Research Organization (CROs)
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Accenture PLC
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Certara
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Charles River Laboratories Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Collaborative Drug Discovery Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Eurofins DiscoverX Products
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Infosys Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 International Business Machines Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Jubilant Biosys Limited
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Oracle Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 PerkinElmer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Selvita
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Drug Discovery Informatics Market: Major Drivers and Challenges
  • Figure 2: Global: Drug Discovery Informatics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Drug Discovery Informatics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Drug Discovery Informatics Market: Breakup by Workflow (in %), 2023
  • Figure 5: Global: Drug Discovery Informatics Market: Breakup by Function (in %), 2023
  • Figure 6: Global: Drug Discovery Informatics Market: Breakup by Mode (in %), 2023
  • Figure 7: Global: Drug Discovery Informatics Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Drug Discovery Informatics Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Drug Discovery Informatics (Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Drug Discovery Informatics (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Drug Discovery Informatics (Drug Development) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Drug Discovery Informatics (Drug Development) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Drug Discovery Informatics (Sequence Analysis Platforms) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Drug Discovery Informatics (Sequence Analysis Platforms) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Drug Discovery Informatics (Molecular Modelling) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Drug Discovery Informatics (Molecular Modelling) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Drug Discovery Informatics (Molecular Docking) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Drug Discovery Informatics (Molecular Docking) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Drug Discovery Informatics (Clinical Trial Data Management) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Drug Discovery Informatics (Clinical Trial Data Management) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Drug Discovery Informatics (Other Functions) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Drug Discovery Informatics (Other Functions) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Drug Discovery Informatics (Outsourced) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Drug Discovery Informatics (Outsourced) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Drug Discovery Informatics (In-house) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Drug Discovery Informatics (In-house) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Drug Discovery Informatics (Pharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Drug Discovery Informatics (Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Drug Discovery Informatics (Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Drug Discovery Informatics (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Drug Discovery Informatics (Contract Research Organization (CROs)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Drug Discovery Informatics (Contract Research Organization (CROs)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Drug Discovery Informatics (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Drug Discovery Informatics (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: North America: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: North America: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: United States: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: United States: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Canada: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Canada: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Asia-Pacific: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Asia-Pacific: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: China: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: China: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Japan: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Japan: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: India: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: India: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: South Korea: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: South Korea: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Australia: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Australia: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Indonesia: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Indonesia: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Others: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Europe: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Europe: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Germany: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Germany: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: France: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: France: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: United Kingdom: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: United Kingdom: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Italy: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Italy: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Spain: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Spain: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Russia: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Russia: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Others: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Latin America: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Latin America: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Brazil: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Brazil: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Mexico: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Mexico: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Others: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Middle East and Africa: Drug Discovery Informatics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Middle East and Africa: Drug Discovery Informatics Market: Breakup by Country (in %), 2023
  • Figure 83: Middle East and Africa: Drug Discovery Informatics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Global: Drug Discovery Informatics Industry: SWOT Analysis
  • Figure 85: Global: Drug Discovery Informatics Industry: Value Chain Analysis
  • Figure 86: Global: Drug Discovery Informatics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Drug Discovery Informatics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Drug Discovery Informatics Market Forecast: Breakup by Workflow (in Million US$), 2024-2032
  • Table 3: Global: Drug Discovery Informatics Market Forecast: Breakup by Function (in Million US$), 2024-2032
  • Table 4: Global: Drug Discovery Informatics Market Forecast: Breakup by Mode (in Million US$), 2024-2032
  • Table 5: Global: Drug Discovery Informatics Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Drug Discovery Informatics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Drug Discovery Informatics Market: Competitive Structure
  • Table 8: Global: Drug Discovery Informatics Market: Key Players